Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia

Published:2013-01 Issue:1 Volume:3 Page:e101-e101
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Brandao L N,Winges A,Christoph S,Sather S,Migdall-Wilson J,Schlegel J,McGranahan A,Gao D,Liang X,DeRyckere D,Graham D K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201246.pdf

Reference36 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ . Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225–249.

2. Kaatsch P . Epidemiology of childhood cancer. Cancer Treat Rev 2010; 36: 277–285.

3. Landier W, Bhatia S . Cancer survivorship: a pediatric perspective. Oncologist 2008; 13: 1181–1192.

4. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572–1582.

5. Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L et al. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol 2003; 21: 3613–3622.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAM family kinases as therapeutic targets at the interface of cancer and immunity;Nature Reviews Clinical Oncology;2023-09-04

2. Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemia;Journal of Controlled Release;2023-09

3. A Novel Prognostic Risk Model for Necroptosis-associated Genes in Acute Lymphoblastic Leukemia;2023-01-10

4. Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia;Cancers;2022-12-13

5. A Novel Prognostic Risk Model for Necroptosis-associated Genes in Acute Lymphoblastic Leukemia;2022-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3